CLEVELAND, Sept. 6, 2016 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Chris Raanes, Chief Executive Officer, and Ajay Bansal, Chief Financial Officer, are scheduled to present at the 18th Annual Rodman & Renshaw Global Investment Conference in New York, NY.
Event: | 18th Annual Rodman & Renshaw Global Investment Conference |
Date: | Monday, September 12, 2016 |
Time: | 3:25 pm ET / 12:25 pm PT |
An audio webcast of the Company’s presentation will be available by clicking here or by visiting the investor relations section of ViewRay’s website at www.viewray.com. A replay of the webcast will be available for 90 days after the date of the presentation.
About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.
ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/viewray-to-present-at-the-18th-annual-rodman--renshaw-global-investment-conference-300323056.html
SOURCE ViewRay, Inc.
